))
Emergency COVID-19 TRIPS Waiver: With U.S. Now Supporting, What’s Next?
Manage episode 365981901 series 3484042
Content provided by Rethink Trade. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rethink Trade or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
On May 5th, the Biden administration announced its support for an emergency COVID-19 waiver of “TRIPS” intellectual property barriers at the World Trade Organization. As we’ve detailed in previous episodes, 100 mainly developing countries have pushed for a TRIPS waiver to facilitate more production of COVID-19 vaccines, tests and treatments around the world.
By reversing the Trump administration block against waiver negotiations, the Biden-Harris administration created momentum for a waiver to be adopted. And made clear saving lives is the priority.
But while we celebrate this historic U.S. announcement and the efforts of people around the world to get a waiver, the Pharma lobby is gearing up to derail, weaken or delay any waiver. In this episode, we reflect on the U.S. campaign for a TRIPS waiver, and the fight still to come as we work to secure the fastest possible agreement on a waiver covering all intellectual property barriers for COVID-19 vaccines, tests & treatments.
Learn more at rethinktrade.org.
Music: Groove Grove by Kevin MacLeod. Link: https://incompetech.filmmusic.io/song/3831-groove-grove. License: http://creativecommons.org/licenses/by/4.0/
68 episoade
Distribuie
